Delivery Order SPE2DB20D2104-SPE2DB25FMPAB

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FB6N1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.71 delivery order contract is for the supply of BRILINTA 90 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL8WK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,968,430 units of the medication BRILINTA 90 MG TABLET 60S. The fixed-price delivery order contract has a ceiling value of $7,509.90 and a performance period ending on April 21, 2025. This award is not associated with a set-aside program and represents an open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,737.60 firm-fixed-price delivery order is for the supply of 4,566,748,470 units of the drug BRILINTA 60 MG TABLET 60S. The contract has an ultimate completion date of December 18, 2024. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF2DH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.06 firm fixed-price delivery order contract is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This award is associated with a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4566615532 BRILINTA 90 MG TABLET 60S. The $1,803.23 firm fixed-price delivery order has an ultimate completion date of December 5, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,000.45 firm fixed-price contract is for the supply of 4,565,768,587 units of the prescription medication BRILINTA 60 MG TABLET 60S. The contract has a completion date of September 12, 2024 and was awarded on September 11, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery...
This federal contract award, valued at $2,171.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of April 9, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,664.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BRILINTA 60 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price arrangement. The award is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,811.68 firm fixed-price delivery order is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of March 4, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,107.59 firm fixed-price delivery order covers the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMPAB
    Delivery Order

This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMPAB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,577.14 firm-fixed-price delivery order is for the supply of 4,567,985,275 units of the prescription medication BRILINTA 90 MG TABLET 60S. The contract has an ultimate completion date of April 22, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This award positions AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/21/25, 7:35 PM